Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 000819.SZ
Valuation Weak
28%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Balanced
50%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 4.99 1.94 1.85
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 52.03 -7.45 -15.54
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 1.59 5.88 5.79
Cash -43.77 1.71 3.04
Capex -62.39 -0.62 -0.38
Free Cash Flow -70.90 -0.69 -0.40
Revenue -8.41 2.07 2.26
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -58.57 0.10 0.23
Operating Margin -10.94 0.03 0.04
ROA -13.68 < 0.005 < 0.005
ROE -22.65 0.01 0.01
ROIC -31.75 < 0.005 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 000819.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 000819.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 000819.SZ is permitted for members.